A single-center retrospective analysis of 1001 consecutively placed NobelActive implants.
This single-center retrospective study evaluated the survival rates of the NobelActive implant (Nobel Biocare AB, Gothenburg, Sweden) with a tapered body design. One thousand and one implants demonstrated a cumulative survival rate of 97.4% (97.1% in maxilla and 98% in the mandible) for up to 31 months of loading.